caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a angiotensin ii antagonist and is hypertension treatment. | CCCCc1nc(Cl)c(CO)n1Cc1ccc(-n2ccc(C)c2C(=O)O)cc1 | [
"hypertension treatment",
"angiotensin ii antagonist"
] |
The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, diabetic heart disease, and aging. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Tangier disease",
"Diabetic heart disease",
"Aging"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Apoptosis",
"Cholesterol translocation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a thrombin inhibitor. | CC(CCCN=CNN)(C(=O)N1CCCC1)c1ccccc1 | [
"thrombin inhibitor"
] |
The molecule is a proliferative disease treatment. | COCCNCCC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2C | [
"proliferative disease treatment"
] |